|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.36 USD | +1.49% |
|
+5.82% | +18.38% |
Company Valuation: The Clorox Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 22,376 | 17,352 | 19,661 | 16,948 | 14,799 | 14,432 | - | - |
| Change | - | -22.45% | 13.31% | -13.8% | -12.68% | -2.48% | - | - |
| Enterprise Value (EV) 1 | 24,841 | 19,880 | 21,821 | 19,231 | 17,120 | 17,065 | 17,800 | 17,643 |
| Change | - | -19.97% | 9.77% | -11.87% | -10.98% | -0.32% | 4.31% | -0.88% |
| P/E ratio | 32.2x | 37.8x | 133x | 60.7x | 18.4x | 21.1x | 18.6x | 17.5x |
| PBR | 53.9x | 31.2x | 89.5x | 51.7x | 45.9x | 558x | 102x | 52.8x |
| PEG | - | -1.1x | -2x | 0.7x | 0x | -1.6x | 1.3x | 2.8x |
| Capitalization / Revenue | 3.05x | 2.44x | 2.66x | 2.39x | 2.08x | 2.22x | 2.09x | 2.02x |
| EV / Revenue | 3.38x | 2.8x | 2.95x | 2.71x | 2.41x | 2.62x | 2.58x | 2.47x |
| EV / EBITDA | 16.9x | 20.4x | 18.9x | 15x | 11.2x | 13.4x | 12.4x | 11.7x |
| EV / EBIT | 19.8x | 26.5x | 23.8x | 18.4x | 13x | 16.2x | 14.7x | 13.7x |
| EV / FCF | 26.3x | 37.2x | 23.5x | 39.8x | 22.5x | 24.5x | 20.4x | 18.8x |
| FCF Yield | 3.8% | 2.69% | 4.26% | 2.51% | 4.45% | 4.09% | 4.91% | 5.32% |
| Dividend per Share 2 | 4.49 | 4.66 | 4.72 | 4.8 | 4.88 | 4.948 | 5.2 | 5.3 |
| Rate of return | 2.5% | 3.31% | 2.97% | 3.52% | 4.06% | 4.15% | 4.36% | 4.44% |
| EPS 2 | 5.58 | 3.73 | 1.2 | 2.25 | 6.52 | 5.644 | 6.424 | 6.825 |
| Distribution rate | 80.5% | 125% | 393% | 213% | 74.8% | 87.7% | 81% | 77.7% |
| Net sales 1 | 7,341 | 7,107 | 7,389 | 7,093 | 7,104 | 6,507 | 6,909 | 7,138 |
| EBITDA 1 | 1,467 | 974 | 1,153 | 1,280 | 1,535 | 1,277 | 1,439 | 1,513 |
| EBIT 1 | 1,256 | 750 | 917 | 1,045 | 1,316 | 1,053 | 1,209 | 1,287 |
| Net income 1 | 710 | 462 | 149 | 280 | 810 | 693.3 | 799.7 | 849.3 |
| Net Debt 1 | 2,465 | 2,528 | 2,160 | 2,283 | 2,321 | 2,633 | 3,368 | 3,211 |
| Reference price 2 | 179.91 | 140.98 | 159.04 | 136.47 | 120.07 | 119.36 | 119.36 | 119.36 |
| Nbr of stocks (in thousands) | 124,372 | 123,080 | 123,624 | 124,188 | 123,253 | 120,912 | - | - |
| Announcement Date | 03/08/21 | 03/08/22 | 02/08/23 | 01/08/24 | 31/07/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 21.15x | 2.62x | 13.37x | 4.15% | 14.43B | ||
| 21.37x | 3.43x | 12.15x | 3.41% | 56.16B | ||
| 30.68x | 4.18x | 18.44x | 1.18% | 24.14B | ||
| 20.27x | 2.41x | 13.41x | 3.84% | 5.18B | ||
| 14.18x | 1.66x | 9.19x | 4.13% | 4.79B | ||
| 39.14x | 4.99x | 26.38x | - | 3.22B | ||
| 18.31x | 0.9x | 7.08x | 1.74% | 3.04B | ||
| 24.62x | 2.81x | 17.31x | 1.86% | 989M | ||
| Average | 23.71x | 2.88x | 14.67x | 2.9% | 13.99B | |
| Weighted average by Cap. | 23.44x | 3.33x | 13.91x | 3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- CLX Stock
- Valuation The Clorox Company
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















